RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2000; 84(02): 352-354
DOI: 10.1055/s-0037-1614021
DOI: 10.1055/s-0037-1614021
Letters to the Editor
Absence of Circulating Factor IX Antigen in Hemophilia B Dogs of the UNC-Chapel Hill Colony
Authors
Weitere Informationen
Publikationsverlauf
Received
26. Januar 2000
Accepted
02. Februar 2000
Publikationsdatum:
14. Dezember 2017 (online)
-
References
- 1 Evans JP, Brinkhous KM, Brayer GD, Reisner HW, High KA. Canine hemophilia B resulting from a point mutation with unusual consequences. Proc Natl Acad Aci USA 1989; 86: 10095-99.
- 2 Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkous KM, Woo SLC. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficientdogs. Science 1993; 262: 117-9.
- 3 Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR. et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 1994; 91: 2353-7.
- 4 Fang B, Wang H, Gordon G, Bellinger DA, Read MS, Brinkhous KM, Woo SLC, Eisensmith RC. Lack of persistent of El- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dog. Gene Ther 1996; 03: 217-22.
- 5 Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 05: 56-63.
- 6 Synder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin H-F, Stafford DW, Patel S, Thompson AR, Nichols T, Read MS, Bellinger DA, Brinkhous KM, Kay MA. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999; 05: 64-70.
- 7 Chao H, Walsh CE. Endogenous FIX antigen exists in Chapel Hill strain hemophilia B canine. Thromb Haemost 1999; 82: 1378.
- 8 Sugahara Y, Catelfamo J, Brooks M, Hitomi E, Bajaj SP, Kurachi K. Isolationand characterization of canine factor IX. Thromb Haemost 1996; 75: 450-55.
- 9 Green PM. et al. Haemophilia B: database of point mutations and short additions and delitions—v9.0. http://www.umds.acuk/molgen (1999)
- 10 O’Farrell P. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-21.
- 11 White T, Lacal J, Reep B, Fischer T, Lapetina E, White G. Thrombolamban, the 22 kilodalton platelet substrate of c AMP-dependent protein kinase, is immunologically homologous with the ras family of GTP-binding proteins. Proc Natl Acad Sci USA 1990; 87: 758-62.